Nektar Therapeutics
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2009 | 57.0% | -132.3% | -142.5% |
| FY2010 | 83.9% | -17.8% | -23.9% |
| FY2011 | 69.4% | -173.4% | -187.4% |
| FY2012 | 62.5% | -173.9% | -211.7% |
| FY2013 | 74.1% | -80.7% | -108.8% |
| FY2014 | 85.8% | -8.2% | -26.9% |
| FY2015 | 85.2% | -12.7% | -35.2% |
| FY2016 | 81.7% | -68.2% | -92.8% |
| FY2017 | 90.1% | -19.4% | -31.4% |
| FY2018 | 98.0% | 57.6% | 57.1% |
| FY2019 | 81.4% | -383.9% | -384.5% |
| FY2020 | 87.3% | -278.0% | -290.6% |
| FY2021 | 75.6% | -437.8% | -514.0% |
| FY2022 | 76.5% | -408.6% | -400.0% |
| FY2023 | 62.5% | -292.6% | -306.3% |
| FY2024 | 68.8% | -106.9% | -120.9% |
| FY2025 | 100.0% | -253.7% | -297.1% |